SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " patient " 3,038 found 🔀 AI-powered Shuffle
NM US Sen. Heinrich tours Albuquerque Food Farmacy to tout fruits and vegetables as medicine
A bill Heinrich co-sponsored aims to study whether Medicare and Medicaid paying for food aid to patients staves off chronic disease.
Partnership Health Center closes Missoula clinics Wednesday over safety concerns
Patients in Missoula will need to make alternate plans for medical care after Partnership Health Center said its Missoula clinics are closed for the remainder o
New Intermountain Health Flight & Ambulance Services base
New Intermountain Health Flight & Ambulance Services base at Intermountain Health St. George Regional Hospital will save response time and enhance patient care
Medicaid Home and Community-Based Services: Supporting Patient Health and Independence
Millions of Americans rely on home and community-based services (HCBS) for critical supports that allow them to live comfortably in their own homes and communities as they age or manage disabilities or chronic conditions. Medicaid is the primary source of coverage for HCBS, helping older adults and Americans with disabilities, including children with complex medical conditions, access healthcare services in their home and familiar settings and providing support for caregivers and family […]
University of Iowa Health Care nixes plans for new $2B tower
University of Iowa Health Care has scrapped plans to build a new $2 billion inpatient tower — at least for now — and rather is “modernizing and expanding existing spaces across the health system, specifically on the university and downtown campuses.”
How Hollywood Shapes Our Understanding of Health
A study sponsored by Eli Lilly and Company (Lilly) shows that chronic illness is historically underrepresented on screen, while a growing coalition of studios, researchers, and patient advocates work to change that reality.
RWJBarnabas Health Opens New Food Farmacy at Monmouth Medical Center
RWJBarnabas Health and Monmouth Medical Center (MMC) today celebrated the grand opening of the system’s sixth Food Farmacy to provide patients with nutritious foods and individualized nutrition counseling from registered dietitians to support long-term health and well-being.
Talent show brings joy to kids at children’s hospital
A weekly talent show at University of Michigan Health C.S. Mott Children's Hospital helps pediatric cancer patients and families find support, healing and happiness through music, magic, and creative expression.
Kane County reports 2nd measles case of 2026, connected to 1st case, in vaccinated patient
Kane County health officials said they have identified a second confirmed case of measles.
More Than 400 Health Care Professionals to Gather in Illinois to Improve Patient Care
/PRNewswire/ -- The American Board of Medical Specialties (ABMS), the leading not-for-profit organization that oversees U.S. physician and medical specialist...
Webinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and Markets
Watch this discussion on how GLP-1 drugs for obesity are changing the shape of U.S. healthcare. From direct-to-consumer portals to pharmacy deals, how these drugs reach patients is changing—and leading to debates over pricing and coverage. Learn how your company can be both patient-forward while also maximizing revenue in this unique environment.
Federal health officials warn Nashville hospital risks losing Medicare deal
Federal health officials are warning Ascension Saint Thomas Hospital that it must quickly fix serious patient-safety problems or risk losing Medicare.
Luma locks down 15-year, $410M fund for life science investments
Luma Group today announced the final close of its inaugural life sciences venture capital fund, totaling $410 million. The New York-based investment firm has had a grip on life sciences since its founding in 2023. The funds unveiled today, dubbed LumaBio Fund I, include investments that have already been made into more than 10 biotechs. They include the likes of eye disease-focused Character Biosciences, rebranded Belgian biotech Coultreon Biopharma and cellular rejuvenation company Altos Labs. The fund saw early success when one of the companies it co-founded, called Vaccine Company, was picked up by Eli Lilly earlier this year for up to $1.55 billion. The acquisition of the in vivo nanoparticle technology-focused biotech formed part of a trio of vaccine buys for the Big Pharma, which has itself been on a prolonged spending spree in 2026. Luma's fund is structured as a 15-year investment with plans to support groundbreaking science and support companies through key milestones from discovery to commercialization, Luma explained in the release. "We founded Luma Group on the belief that extraordinary science, supported by patient, long-term capital, has the power to improve millions of lives," Joshua Fink, founder and managing member of Luma Group, said in the release. "This fund represents more than capital—it is a commitment to partnering with extraordinary innovators as they translate visionary science into life-changing medicines."
ECMO saves newborn with severe lung damage after RSV scare
At just 2 weeks old, Jocelyn Selle was flown to Sanford Children's Hospital in Sioux Falls -- the only home for ECMO treatment in the Dakotas.
The Cost of Cutting American Science: How Federal Cuts Diminish Public Health Capacity
Among the federal government’s many responsibilities is the work it does to protect public health. Federal agencies monitor our food supply to ensure safety, conduct research to better understand emerging health threats, provide funding for public health programs in communities and work to detect and respond to disease outbreaks. Americans rely on these efforts every day—in a 2024 online survey, 74% of respondents said that “if the federal government issued safety guidance about food you eat regularly,” they would follow it. Changes to Federal Public Health Capacity The Trump administration’s efforts to reshape the federal government have resulted in significant impacts on our nation’s public health capacity over the past 20 months, affecting the response to health concerns such as measles, Ebola and cyclosporiasis. Agencies with core public health, food safety and disease prevention responsibilities experienced large workforce decreases during the first year of the administration. At the Centers for Disease Control and Prevention, for instance, the workforce in February 2026 was 26.7% smaller than in September 2024 before the start of the Trump administration. The Food and Drug Administration saw a similarly steep decline of 21.6%. Agencies such as the National Institutes of Health, Substance Abuse and Mental Health Services Administration and Food Safety and Inspection Service also experienced large workforce decreases. (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); Changes can also be seen in crucial public health occupations. The number of federal food inspectors, for example, decreased by more than half between September 2024 and February 2026, going from 1,035 to 473. This is the lowest number of food inspectors employed by the federal government since at least 2005. By February 2026, there were also 33.3% fewer federal public health program specialists, whose work includes advising federal funding recipients on public health activities and analyzing the effectiveness of public health programs. Government’s capacity is diminished as employees with specialized knowledge and experience in protecting the public and responding to health risks depart, leaving agencies less prepared to carry out their public health missions. There also have been vacancies in critical high-level leadership positions at public health agencies, most notably at the CDC, which had a permanent Senate-confirmed director for less than a month between January 2025 and early August 2026. Although the CDC has previously been led by acting directors at the start of an administration, the nearly yearlong gap since the departure of the administration’s first permanent director in August 2025 is without precedent. As of August 2026, the FDA is also currently without a Senate-confirmed commissioner following the previous commissioner’s resignation in May 2026. Additionally, public health agencies are experiencing increased politicization of their leadership ranks. In agencies such as the CDC and Food Safety and Inspection Service, the number of individuals in the Senior Executive Service—the most senior career leaders in government—has declined significantly, while at the same time the number of political appointees has reached record levels. (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); At the CDC, for example, the number of career SES decreased 42.9% between December 2024 and February 2026, while the number of non-Senate confirmed political appointees at the agency was six times larger than the agency’s historical average from 2009 and 2024. Knowledgeable career leaders are integral to the ability of public health agencies to carry out their work with scientific integrity and professional judgment, and rapid leadership turnover and increased politicization threaten agencies’ ability to make evidence-based decisions to protect our health. The upheaval and politicization in public health agencies have also negatively affected employee engagement. Strong employee engagement is crucial to the ability of agencies to carry out their mission and successfully provide essential services to the public. In the 2025 Public Service Viewpoint Survey conducted by the Partnership for Public Service, the Department of Health and Human Services—which encompasses major public health agencies such as the CDC and FDA—had an employee engagement and satisfaction score of 20.4 out of 100, one of the lowest among large agencies. Only 2.8% of HHS employees indicated trust in their political leaders and only 8.7% reported confidence that they could report a suspected violation of law or regulation without retaliation. Employees at HHS also reported that the agency’s ability to provide services to the public had suffered. Nearly half of employees at HHS, 47.5%, said their work unit was worse at delivering quality services compared to its performance in 2024. In addition, 57.8% said their work unit was performing worse at fulfilling stakeholder needs. In addition to the work done within federal agencies, the federal government also distributes significant funding for public health and disease prevention work to state and local governments, nonprofits and small businesses—funding which has been significantly disrupted. At the CDC, for example, there was a 71.9% decrease in the amount of project grant funding issued in fiscal year 2025 compared to fiscal year 2024. The FDA also issued far less funding in fiscal year 2025—a 21.3% decrease from its fiscal year 2024 funding. Changes in federal funding include the ending of grants to community organizations that worked on HIV prevention and the cancellation of funding for research into improvements to patient safety and healthcare quality. These changes go beyond federal agencies to impact the broader public health ecosystem, including the state and local health departments responsible for much of the on-the-ground public health work in their communities. About 80% of the CDC’s domestic funding is directed towards state and local partners—meaning that cuts to CDC funding can ultimately result in cuts to state and local public health capacity. Federal agencies also provide expertise and assistance to state and local health agencies as they deal with particular health challenges, but workforce cuts have resulted in fewer federal employees available to help. The Impact of Changes to Public Health Capacity These changes to federal public health capacity are not abstract concerns. Disrupted programs, reduced funding and lost expertise at public health agencies across all levels of government threaten the public’s physical well-being and safety. In some cases, this has already led to harm. The most immediate impacts of federal cuts were seen in interruptions to ongoing public health programs and crisis responses. In one instance, when CDC grants were canceled during the 2025 Texas measles outbreak—the most severe measles outbreak in 25 years—public health officials in Lubbock, Texas were forced to pause parts of their measles response work supported by the frozen funding. Lubbock’s director of public health further said that a lack of available CDC experts to reach out to for advice “definitely” impacted the department’s response to the measles crisis. Cuts to federal funding also forced Dallas County Health and Human Services to cut staff and cancel 50 community vaccination clinics during the outbreak. Public health work outside of major outbreak responses was also disrupted. For example, in April 2025, the Milwaukee Public Health Department was unexpectedly unable to reach experts on lead poisoning due to firings at the CDC when responding to concerns about lead contamination in Milwaukee public schools. Due to federal workforce cuts, several programs at the CDC, including Alzheimer’s and epilepsy programs, have also become trapped in limbo—existing on paper, but without the staff necessary to operate. More recent crises reveal how federal cuts have weakened the public health infrastructure needed to prevent and respond to dangerous new outbreaks. Internationally, cuts at the U.S. Agency for International Development eliminated funding for disease testing and contact tracing abroad, which delayed detection of and responses to the 2026 Ebola outbreak in the Democratic Republic of Congo. While international outbreaks may seem far removed, the unchecked spread of disease in any country can quickly pose a danger to economic well-being, security and health around the world. Within the United States, public health cuts inhibited responses to the summer 2026 outbreak of the food-borne parasite cyclospora. At the federal level, cuts to funding for lab equipment and for CDC staff with expertise in parasitic infections—including 9 out of 11 staff members at the lab responsible for identifying parasitic outbreaks in 2025— contributed to the largest reporting delay in outbreak cases at the CDC in 15 years. Conflicting communications from the FDA about the source of the outbreak, which followed cuts to the agency’s communications department, additionally led to confusion among the public about how to best avoid infection. At the same time, cuts to HHS funding and support for local and state public health slowed some health departments’ responses to the crisis. The exact costs of these delays, constraints and confusion in public health responses are difficult to estimate. However, their message is clear: federal cuts have already made containing threats to public health even more of a challenge. Conclusion Protecting public health—from food safety to disease prevention—is one of the federal government’s most important missions. Dramatic and haphazard cuts to federal agencies and funding have already disrupted the public health system, impacting the response to challenges such as measles, lead poisoning and cyclosporiasis. The U.S. public health system needed improvement before these disruptions. Since 2022, federal leadership and coordination in response to public health outbreaks has been on the Government Accountability Office’s High-Risk List of areas in need of attention to improve government effectiveness and efficiency. Recent cuts only compound these concerns. The chaotic dismantling of government and resulting disruptions to crucial functions like public health and disease prevention highlight the need for meaningful reform and concrete policy proposals to reimagine how government can better serve the public and be more effective, responsive and accountable. To learn more about the impact of federal cuts to public health and science more broadly, visit The Cost of Cutting American Science. Learn more For more information on the Partnership for Public Service’s government reform initiative, visit Government for a New Era. View here In line with The Cost of Cutting American Science, federal workforce data in this brief is as of February 2026
The Cost of Cutting American Science: How Federal Cuts Diminish Public Health Capacity
Among the federal government’s many responsibilities is the work it does to protect public health. Federal agencies monitor our food supply to ensure safety, conduct research to better understand emerging health threats, provide funding for public health programs in communities and work to detect and respond to disease outbreaks. Americans rely on these efforts every day—in a 2024 online survey, 74% of respondents said that “if the federal government issued safety guidance about food you eat regularly,” they would follow it. Changes to Federal Public Health Capacity The Trump administration’s efforts to reshape the federal government have resulted in significant impacts on our nation’s public health capacity over the past 20 months, affecting the response to health concerns such as measles, Ebola and cyclosporiasis. Agencies with core public health, food safety and disease prevention responsibilities experienced large workforce decreases during the first year of the administration. At the Centers for Disease Control and Prevention, for instance, the workforce in February 2026 was 26.7% smaller than in September 2024 before the start of the Trump administration. The Food and Drug Administration saw a similarly steep decline of 21.6%. Agencies such as the National Institutes of Health, Substance Abuse and Mental Health Services Administration and Food Safety and Inspection Service also experienced large workforce decreases. (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); Changes can also be seen in crucial public health occupations. The number of federal food inspectors, for example, decreased by more than half between September 2024 and February 2026, going from 1,035 to 473. This is the lowest number of food inspectors employed by the federal government since at least 2005. By February 2026, there were also 33.3% fewer federal public health program specialists, whose work includes advising federal funding recipients on public health activities and analyzing the effectiveness of public health programs. Government’s capacity is diminished as employees with specialized knowledge and experience in protecting the public and responding to health risks depart, leaving agencies less prepared to carry out their public health missions. There also have been vacancies in critical high-level leadership positions at public health agencies, most notably at the CDC, which had a permanent Senate-confirmed director for less than a month between January 2025 and early August 2026. Although the CDC has previously been led by acting directors at the start of an administration, the nearly yearlong gap since the departure of the administration’s first permanent director in August 2025 is without precedent. As of August 2026, the FDA is also currently without a Senate-confirmed commissioner following the previous commissioner’s resignation in May 2026. Additionally, public health agencies are experiencing increased politicization of their leadership ranks. In agencies such as the CDC and Food Safety and Inspection Service, the number of individuals in the Senior Executive Service—the most senior career leaders in government—has declined significantly, while at the same time the number of political appointees has reached record levels. (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); At the CDC, for example, the number of career SES decreased 42.9% between December 2024 and February 2026, while the number of non-Senate confirmed political appointees at the agency was six times larger than the agency’s historical average from 2009 and 2024. Knowledgeable career leaders are integral to the ability of public health agencies to carry out their work with scientific integrity and professional judgment, and rapid leadership turnover and increased politicization threaten agencies’ ability to make evidence-based decisions to protect our health. The upheaval and politicization in public health agencies have also negatively affected employee engagement. Strong employee engagement is crucial to the ability of agencies to carry out their mission and successfully provide essential services to the public. In the 2025 Public Service Viewpoint Survey conducted by the Partnership for Public Service, the Department of Health and Human Services—which encompasses major public health agencies such as the CDC and FDA—had an employee engagement and satisfaction score of 20.4 out of 100, one of the lowest among large agencies. Only 2.8% of HHS employees indicated trust in their political leaders and only 8.7% reported confidence that they could report a suspected violation of law or regulation without retaliation. Employees at HHS also reported that the agency’s ability to provide services to the public had suffered. Nearly half of employees at HHS, 47.5%, said their work unit was worse at delivering quality services compared to its performance in 2024. In addition, 57.8% said their work unit was performing worse at fulfilling stakeholder needs. In addition to the work done within federal agencies, the federal government also distributes significant funding for public health and disease prevention work to state and local governments, nonprofits and small businesses—funding which has been significantly disrupted. At the CDC, for example, there was a 71.9% decrease in the amount of project grant funding issued in fiscal year 2025 compared to fiscal year 2024. The FDA also issued far less funding in fiscal year 2025—a 21.3% decrease from its fiscal year 2024 funding. Changes in federal funding include the ending of grants to community organizations that worked on HIV prevention and the cancellation of funding for research into improvements to patient safety and healthcare quality. These changes go beyond federal agencies to impact the broader public health ecosystem, including the state and local health departments responsible for much of the on-the-ground public health work in their communities. About 80% of the CDC’s domestic funding is directed towards state and local partners—meaning that cuts to CDC funding can ultimately result in cuts to state and local public health capacity. Federal agencies also provide expertise and assistance to state and local health agencies as they deal with particular health challenges, but workforce cuts have resulted in fewer federal employees available to help. The Impact of Changes to Public Health Capacity These changes to federal public health capacity are not abstract concerns. Disrupted programs, reduced funding and lost expertise at public health agencies across all levels of government threaten the public’s physical well-being and safety. In some cases, this has already led to harm. The most immediate impacts of federal cuts were seen in interruptions to ongoing public health programs and crisis responses. In one instance, when CDC grants were canceled during the 2025 Texas measles outbreak—the most severe measles outbreak in 25 years—public health officials in Lubbock, Texas were forced to pause parts of their measles response work supported by the frozen funding. Lubbock’s director of public health further said that a lack of available CDC experts to reach out to for advice “definitely” impacted the department’s response to the measles crisis. Cuts to federal funding also forced Dallas County Health and Human Services to cut staff and cancel 50 community vaccination clinics during the outbreak. Public health work outside of major outbreak responses was also disrupted. For example, in April 2025, the Milwaukee Public Health Department was unexpectedly unable to reach experts on lead poisoning due to firings at the CDC when responding to concerns about lead contamination in Milwaukee public schools. Due to federal workforce cuts, several programs at the CDC, including Alzheimer’s and epilepsy programs, have also become trapped in limbo—existing on paper, but without the staff necessary to operate. More recent crises reveal how federal cuts have weakened the public health infrastructure needed to prevent and respond to dangerous new outbreaks. Internationally, cuts at the U.S. Agency for International Development eliminated funding for disease testing and contact tracing abroad, which delayed detection of and responses to the 2026 Ebola outbreak in the Democratic Republic of Congo. While international outbreaks may seem far removed, the unchecked spread of disease in any country can quickly pose a danger to economic well-being, security and health around the world. Within the United States, public health cuts inhibited responses to the summer 2026 outbreak of the food-borne parasite cyclospora. At the federal level, cuts to funding for lab equipment and for CDC staff with expertise in parasitic infections—including 9 out of 11 staff members at the lab responsible for identifying parasitic outbreaks in 2025— contributed to the largest reporting delay in outbreak cases at the CDC in 15 years. Conflicting communications from the FDA about the source of the outbreak, which followed cuts to the agency’s communications department, additionally led to confusion among the public about how to best avoid infection. At the same time, cuts to HHS funding and support for local and state public health slowed some health departments’ responses to the crisis. The exact costs of these delays, constraints and confusion in public health responses are difficult to estimate. However, their message is clear: federal cuts have already made containing threats to public health even more of a challenge. Conclusion Protecting public health—from food safety to disease prevention—is one of the federal government’s most important missions. Dramatic and haphazard cuts to federal agencies and funding have already disrupted the public health system, impacting the response to challenges such as measles, lead poisoning and cyclosporiasis. The U.S. public health system needed improvement before these disruptions. Since 2022, federal leadership and coordination in response to public health outbreaks has been on the Government Accountability Office’s High-Risk List of areas in need of attention to improve government effectiveness and efficiency. Recent cuts only compound these concerns. The chaotic dismantling of government and resulting disruptions to crucial functions like public health and disease prevention highlight the need for meaningful reform and concrete policy proposals to reimagine how government can better serve the public and be more effective, responsive and accountable. To learn more about the impact of federal cuts to public health and science more broadly, visit The Cost of Cutting American Science. Learn more For more information on the Partnership for Public Service’s government reform initiative, visit Government for a New Era. View here In line with The Cost of Cutting American Science, federal workforce data in this brief is as of February 2026
California sanctions insurer after it cut assisted living coverage to thousands
State regulators found eight violations after Health Net's abrupt benefit cuts endangered vulnerable Medi-Cal patients.
New Eugene facility will expand Oregon’s residential behavioral health system for youth
A 12-bed secure inpatient treatment facility in Eugene will serve youth ages 10-17 with acute behavioral health needs.
FBI raided his Detroit drug rehab centers. Now he can't pay employees.
A drug rehab center in metro Detroit says the FBI has seized all of its money, causing paychecks to bounce and leaving patients with nowhere to go.
St. John’s Health revamps phone scheduling
It can be hard for St. John’s Health patients to schedule appointments on the phone. The hospital is now hoping to change that.
Democrats demand Trump administration halt collection of patients’ ER records
A group of Democratic lawmakers is calling for the Trump administration to suspend a new surveillance program it quietly launched to collect the personal and identifiable health data of Americans who visit emergency rooms.
The Market Forces Quietly Adding Thousands To Patient Bills
By Elisabeth Rosenthal and KFF Health News HealthDay ReportersWEDNESDAY, Sept. 9, 2026 (HealthDay News) — After a failed round of in vitro fertilization this year, Anne Hug’s fertility doctor said she had a single polyp in her uterus that should be removed to improve the chance of pregnancy. Hug, a ...
Epic v. Health Gorilla: “Working as Designed”
We’ve been on a bit of a legal bender since just before Labor Day, so let’s keep a good thing going! As predicted, Epic does not want its case against Health Gorilla consolidated with the data breach cases, so it filed a motion to vacate the conditional transfer. And because they had to explain to the Panel why this case is different, they put a good chunk of previously unseen Epic v. Health Gorilla discovery record on the public docket! Roll the tape! The Case Against Consolidation Before we get to the fun stuff, let’s do the housekeeping. Epic's motion boils down to three arguments (sorted in ascending order of how well they land): A judge has already decided this. Judge Olguin declined to relate the fraud action to another ELU case (Patterson v. UVA Health), holding that the two do not call for determination of substantially similar questions of law or fact. Epic asks the Panel to treat that (a Rule 42 ruling) as law of the case. The overlap is thin. The three common questions Health Gorilla and the Panel identified are neither numerous nor complex (the qualities the Panel looks for before centralizing). Moreover, they are outnumbered by the questions unique to each side: The breach cases turn on security architecture, notification timing, and patient-level access. The fraud action turns on false treatment attestations and breaches of the framework agreements. Consolidation costs more than it saves. 17 of 21 parties in the fraud action do not appear in a breach case. The cases are also at very different stages: Olguin has a scheduling order running through a January 2028 trial while the breach actions are much more nascent. I like the last two more than the first because they attack the basic economics of an MDL: there just may not be enough shared discovery here to justify dragging all the defendants and a relatively mature fraud case all the way to Florida. On the other hand (while I know exceedingly little about MDL and Rule 42), I have a hard time seeing why a district judge's decision about his own docket would control what the Panel does with the separate § 1407 question. I might be reading between the lines too much, but I sorta think Epic's own brief half-concedes this, framing the two provisions as "two sides of the same coin" but then adding "respectfully submit" (which is often lawyer speak for “we know this is a reach”). The Ladder Gets More Rungs Anyway, the arguments are not why you're here (aside from the lawyers, maybe). Back in June, we discussed how Epic was using the smaller defendants to build an evidentiary ladder toward Health Gorilla and Unit 387. Turns out discovery has been adding a few rungs of its own.
New outpatient clinic focused on suicide prevention opens in Burlington
University of Vermont Health held an open house last week to celebrate the opening of the Asha Clinic, which it describes as the only program in the region focused exclusively on suicide care. The clinic's work is led by Craig Bryan, an expert in suicide treatment and research.
Lindsay Clancy and postpartum psychosis
The trial around Lindsay Clancy may be over for now, but it still leaves us with questions. On today’s episode, we talk to psychiatrists and patients to answer them: What is postpartum psychosis, exactly? Why don’t we know more about it? And what can you do if you are worried about a postpartum loved one?Interested in more stories on mental health? Email us your question at shortwave@npr.org.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org.
The bill for Trump’s Medicaid cuts is coming due
Though much attention has centered on the closure of rural hospitals, quieter transformations could reshape healthcare for all patients.
Independent Kansas health systems launch shared services organization
Five Kansas health systems have launched a regional collaboration, called Astra Health, to pool resources and coordinate services while retaining their independence. | Astra Health's five founding members, who serve more than half a million patients annually, hope to improve quality and trim costs at scale while maintaining their independence.
The Villages Health’s $541 million settlement highlights the cost of ‘upcoding’
The settlement describes how The Villages Health would go back into patients' medical files months later and add diagnoses -- sometimes adding in monitoring, evaluations or treatments.
Drug developed for lung disease may slow biological aging in surprising ‘bonus’
Rentosertib, an AI-discovered drug for idiopathic pulmonary fibrosis, made patients appear three to four years biologically younger in a clinical trial.
Sanford Health Patient Advances Suit Over Meta Data Disclosures
Sanford Health Corp. failed to convince a federal judge to toss a proposed class action alleging the Minnesota-based health system collected and disclosed patients’ personal information in violation of state and federal laws.
Democrats Demand Trump Administration Halt Collection of Patients' ER Records
Senate and House Democrats say the Trump administration’s plan to collect patients’ medical data violates privacy and will discourage people from seeking medical care.
New Cancer Care Technology at Intermountain Health St. Mary’s Improves Precision and Comfort for Western Colorado Patients
Intermountain Health St. Mary’s Regional Hospital has invested more than $2 million for new equipment and technology to improve quality of care and comfort of their patients receiving cancer care in the Grand Junction area.St. Mary’s Cancer Centers of Colorado purchased a new a new computed tomography (CT) scanner that offers several enhance...
Politics Threaten Medical Innovation at NIH
Santa Monica rheumatologist warns that political interference in NIH funding threatens scientific breakthroughs and patient care. Taxpayer dollars should support rigorous peer review, not politics.
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.
Memorial Hermann Health System Clinicians Use Epic's AI Tool to Help Patients Better Understand Test Results
/PRNewswire/ -- Clinicians at Memorial Hermann Health System (MHHS) are using a new artificial intelligence (AI) tool built directly into Epic to help patients...
LMH Health announces participation in Astra Health to expand access, improve care and reduce healthcare costs
We are pleased to announce that LMH Health is one of five independent Kansas health systems joining together to form Astra Health, a new regional healthcare collaboration designed to improve patient care, strengthen access to specialty services, and deliver more affordable healthcare options for employers and communities across Kansas. By working together, participating health systems […]
Health Column: Helping patients feel comfortable in their own skin
Content provided by Memorial Regional Health. When people think about dermatology, they often think about treating skin conditions like eczema, psoriasis, acne, or suspicious moles. But for Emma Rodgers, NP-C, dermatology is also about something...
Qualderm and Parakeet Health Partner to Expand Patient Access Across National Dermatology Network
/PRNewswire/ -- Parakeet Health, a healthcare AI company that is transforming patient engagement at enterprise scale, and Qualderm, a management services...
Why consumer apps set their sights on patient health records
Apps like Doctronic, Sharecare & ChatGPT now let patients access medical records via AI, aided by TEFCA & CMS, though Epic's data-sharing friction remains a hurdle.
Qualderm and Parakeet Health Partner to Expand Patient Access Across National Dermatology Network
Parakeet Health, a healthcare AI company that is transforming patient engagement at enterprise scale, and Qualderm, a management services organization for a national physician-led skin care network, today announced a collaboration to expand patient access, strengthen care continuity and reconnect patients following cancellations, missed visits, and overdue follow-ups.
MDI Health to Honor Mount Desert Nursing Association with 2026 Impact Award
BAR HARBOR—MDI Health will honor Mount Desert Nursing Association (MDNA) as its 2026 Community Partner of the Year during the organization’s Annual Meeting and Community Celebration on Tuesday, September 15. MDNA will receive the 2026 Impact Award in recognition of its longstanding commitment to providing in-home nursing, physical and occupational therapy, and medical equipment to the Island region. By caring for people where they live, MDNA helps patients remain safely and independently at home, providing reassurance and support to their families. “Mount Desert Nursing Association exemplifies the power of community partnership,” said Chrissi Maguire, President and CEO of MDI Health. “Its nurses bring skilled, compassionate care directly into people’s homes, helping patients navigate illness, recovery, and some of life’s most difficult moments. We are deeply grateful for MDNA’s service and the important role it plays in the health of our community.” MDNA works closely with MDI Health providers and care teams to support continuity of care following hospitalization, surgery, illness, or changes in health. Its personalized services extend care beyond the hospital and help ensure patients receive the support they need close to home. “For 77 years, MDNA has been here for our community, helping our neighbors recover and remain safely at home. Our long-standing partnership with MDI Health is an important part of making that possible. Together, we help ensure a seamless transition from hospital to home and provide patients with the continued care they need. We are incredibly grateful for this recognition and especially proud of our talented and hardworking team,” said Amy McVety, Executive Director of Mount Desert Nursing Association. The Impact Award will be presented during MDI Health’s Community Celebration from 5 to 7 p.m. at the Bar Harbor Club. The event will also recognize outstanding employees, volunteers, and trustees; celebrate MDI Health’s achievements over the past year; and mark a transition in Board leadership as Madeleine Braun, PhD, MBA, prepares to succeed Martha Wagner, PhD, as chair. The celebration will feature music, refreshments, the MDI Health Auxiliary Raffle, and a cash bar. MDI Health’s Annual Business Meeting will take place from 3:30 to 4 p.m. via Zoom. These events are free and open to the public, but space is limited. To reserve your spot, contact Patrianna Anderson at 207-288-5082, ext. 1432, or visit mdihospital.org/communitycelebration. Subscribe Share Leave a comment
Why executives make bad patients — and how three Triangle leaders say to fix that
Business leaders discuss recovery challenges at Triangle Business Journal panel featuring Chip Payne of Precision Packaging Services and medical experts.
Hawaii County panel approves $90M Keaau Health Center
A Hawaii County panel has cleared the way for Hilo Benioff Medical Center to build an outpatient medical clinic in Keaau.
'I'm ready to try and establish myself'
Bournemouth forward Daniel Jebbison says he is "ready" to make an impact whenever he is given the nod by Marco Rose this season. Jebbison has completed two loan spells at Championship outfits Watford and Preston North End in recent seasons and is hopeful those experiences will now help him "establish" himself with the Cherries. "I'm ready and I'm patient," Jebbison said.
Inhaled Microplastics Linked To Lung Cancer, Study Finds
By Dennis Thompson HealthDay ReporterTUESDAY, Sept. 8, 2026 (HealthDay News) — People with lung cancer are more likely to have hidden deposits of microplastics in their lungs, a new study says. About 66% of lung cancer patients had detectable microplastics found in fluid samples taken from their ...
Swing FORE Women's Health tournament raises more than $16,000 for Hahne Cancer Center patients
DuBOIS — The Treasure Lake Women’s Golf Association’s annual Swing FORE Women’s Health golf tournament raised more than $16,000 to support local cancer patients and their families.
The Market Forces Quietly Adding Thousands to Patient Bills
The true cost of “vertical integration”: patients directed to a higher-priced location for procedures. Or forced to buy from their insurer’s wholly owned pharmacy, which may not stock the drug prescribed or provide it at the lowest price.
FaithCare Global Missions Conference and Banquet to Bring Healthcare and Mission Communities Together
On the heels of a successful medical mission trip that reached 1,727 patients in Nigeria, FaithCare will unite healthcare professionals, students, missionaries, churches, and community members for its annual conference and banquet in Berks County.
“It’s normal” Kessie breaks silence on snubbing Juventus for Atalanta
Franck Kessie was widely expected to move to Juventus this summer as a free agent, and he tried his best to make the transfer happen. The midfielder waited patiently for Juve to offload some players a...
Europe has plans for cancer and heart disease – lung health is still waiting
Getting respiratory care right could help patients, ease hospital pressure and cut emissions all at once – but Europe still lacks a plan to make it happen
Sudan health system faces collapse, Doctors Without Borders says
Sudan's healthcare system is on the brink of collapse as cuts to aid funding force clinics and outpatient facilities to close across the war-torn country, Doctors Without Borders (MSF) said. The organ...
UT Health San Antonio invests $1 billion to meet the growing demand for healthcare in South Texas
The multiyear investment strengthens patient care, research and healthcare infrastructure.
Longtime Baxter Health nurse joins gastroenterology clinic as nurse practitioner
Kirsten Cotter, a registered nurse at Baxter Health since 2001, will begin seeing patients Tuesday, Sept. 8, as an advanced practice registered nurse at the Baxter Health Gastroenterology Clinic. Cotter joins Dr. Abodunrin S. Badejo, Dr. William S. Dyer Sr., and nurse practitioners Patricia Acklin, Kimber Jensen and Amanda Stricklin at the clinic, according to
A men's health doctor says many men with low testosterone are getting misdiagnosed — and missing lab tests could be why
Sometimes men are treated for depression when low testosterone is the real cause. A men's health physician explains the signs, the tests, and what to do next.
Corewell and healthcare firm to build Sterling Heights rehab hospital
The 84-bed hospital will be dedicated to patients recovering from stroke, spinal cord and brain injuries, amputations and some orthopedic conditions.
Scientists Discover a Hidden Defect That Could Explain Why IBD Keeps Coming Back
A hidden molecular defect in inflammatory bowel disease may help explain why flare-ups can return even when patients appear well. Even when inflammatory bowel disease appears under control, intestinal cells may remain primed to die. In a WEHI-led study, researchers found this hidden molecular defect in patients with few or no symptoms, and higher levels
Is investing in mental health an overlooked opportunity?
EXPERT INSIGHT: If you’re an impact investor, what’s your first reaction to mental health? Do you immediately think of founders’ wellbeing, of highly scalable, AI-enabled therapy apps, or do you believe it’s a personal topic that isn’t investable at all?
Navy Medicine Advances Operational Health IT for Distributed Maritime Operations
CHESAPEAKE —Navy Medicine leaders, Fleet representatives, and operational health IT experts convened to accelerate the fielding of medical information capabilities designed to support patient movement, medical logistics and force readiness
‘Mistrust’ of Palantir may affect NHS research, says health minister
James Frith warns patients may be less willing to share data as new figures show a rise in opt-outs
Yale doctor on caring for mental health in cancer patients
NEW HAVEN, Conn. (WTNH) — The mental state of cancer patients is a part of care that many people may not think about. Gabe Cartagena, Ph.D., the clinical director of the Yale Psycho-Oncology Progra…
Cravings ‘like heroin withdrawal’: what happens when weight-loss drugs don’t work?
GLP-1 medications have been a gamechanger in the fight against obesity. But for a minority of patients, their impact is negligible. Why?
Language Access: A Strategic Performance Driver for Providers
Learn how a total cost of ownership approach to language access can improve efficiency, patient outcomes, compliance and financial performance.
HOMETOWN HEALTH: A-I might be giving you dangerous advice about sleep apnea
AI chatbots gave dangerous medical advice to sleep apnea patients.
Union healthcare workers protect NJ patients when laws and regulators cannot
Healthcare workers and patients face a growing threat that cannot be addressed through collective bargaining alone, nurse Debbie White writes.
Green light for Keaau Health Center: Commissioners OK $90M project
The Windward Planning Commission on Thursday cleared the way for Hilo Benioff Medical Center to build an outpatient medical clinic in Keaau.
92% of Health Providers Want Patients to Prepay
Americans are being asked to pay for costly medical procedures up front. Roughly 92% of U.S. health providers this year are either encouraging prepayment,
Leaving a legacy at Lee Health
Healthcare has always been an essential lifeline worldwide; nobody can beat the flu with their own two fists. It takes a team of doctors, nurses, therapists, surgeons and many other health care professionals to care for patients and help people reach a healthy, fulfilling life. For Southwest Florida locals, the name Lee Health is a
Emplify Health is Transitioning its Inpatient Rehabilitation Unit
Emplify Health by Bellin has partnered with Ernest Health to transform its Rehabilitation Center. Earnest Heal...
A $480,000-a-year pill reflects a new normal for cancer drugs
Cancer drug prices have steadily increased. The expense is borne by government programs like Medicare, employers, patients and Americans who pay taxes and health insurance premiums.
UVA Health first in Virginia to implant new temporary heart pump in pediatric patient
The new Impella device is placed in a vein and works longer than traditional heart pumps, and allows more mobility
Kokua Line: Why can’t new business register with state?
Question: Can you check what is going on with the slow approval times at the State of Hawaii DCCA Business Registration Office? Historically, if you paid the expedited review fee, your registration documents for a new entity would be approved within a week or sooner. Now, even paying the expedited review fee, I have been patiently waiting for months. My filing to form a new business submitted in June still has not been approved. Without the state’s approval, I cannot open a bank account, sign a lease, hire employees, or start my business. This has resulted in damages due to the delays. My emails to the DCCA have not been responded to. I heard that there is an issue with a new vendor of their supposed updated system, but forming a new business or other business registration tasks seem to have come to a standstill. I heard that they are working on May submissions now. I cannot believe that this unacceptable delay has not been publicized, complaints from the public more prevalent, and the elected officials not having been told by their constituents to immediately address this problem.
Vernon Health announces new Soldiers Grove space to expand access to care
Sept. 5, 2026 VIROQUA, Wis. — Vernon Health announced plans to move into a new facility in Soldiers Grove, a step officials said would expand access to care for residents of Soldiers Grove and surrounding communities. The move continued Vernon Health’s commitment to providing care closer to where patients live. Officials said the new location […]
Stephens County Hospital Administrators discuss joining Wellstar Health System
Wellstar Health System and Stephens County Hospital have reached an agreement for Stephens County Hospital to become part of Wellstar Health System. Stephens County Hospital Chief Executive Officer Van Loskoski says this opens up a depth of resources and services. “It opens up a depth of resources and services that is going to be really meaningful for the patients that [...]
Cancer patient feels "like collateral damage" after MGB Health Plan removes Dana-Farber from Medicare Advantage network
Is UT Tyler Specialty Expansion Reframing the Investment Case for Ardent Health (ARDT)?
Ardent Health recently marked a milestone in its East Texas partnership as UT Health East Texas expanded specialty care into the UT Tyler School of Medicine Building in Tyler, bringing women’s health, pulmonary, orthopedic, imaging and surgical services alongside the region’s first medical school. This integration of patient care and physician training, supported by more than US$315 million of capital investment since 2018 and a provider network that has grown by 116%, underscores Ardent’s...
Low-income patients at UCLA Health scramble to find new doctors as contract ends
Thousands of low-income patients, some desperately ill, are scrambling to find new doctors as they lose access to UCLA Health physicians after an eight-year Medi-Cal contract was not renewed.
Health care is Democrats' key to winning midterms this fall
Breaking up the health care conglomerates that have enriched themselves by immiserating patients and cheating employers is good policy.
Texas doctor loses license for prescribing ‘abortive’ to patient
The doctor allegedly had a sexual relationship with a patient and then prescribed her an “abortive.” Nearly all abortions are illegal in Texas, under a strict abortion ban.
Community Health Care Clinic in Normal sees influx of patients tied to Medicaid cuts
Executive Director Holly Wayland-Hall said the clinic's mission is charity-based, providing health services to people who are uninsured, or have recently lost coverage through Medicaid. She said 99% of the clinic's patients have no insurance.
UVM Health opens new outpatient clinic with leader in suicide care at the helm
The 100-patient clinic seeks to expand Vermont’s capacity to treat suicidal thinking while also broadening research into the condition.
380 SSM Health Dean Medical Group nurses to vote on union in Dane County
Nurses will vote on union representation at 10 Dane County clinics, citing staffing, burnout and patient care.
Vote in HME Business Product of the Year Competition
Innovation is the lifeblood of the durable medical equipment industry. It’s not technology for technology’s sake — it’s improving the outcomes, quality of life, inclusion and everyday abilities for patients across the country. Here’s your chance to directly recognize innovations you think are moving the industry — and most importantly, its patients — forward. Voting…
How Medicaid ACOs Can Lead the US Towards Maternal Health Equity
A new study details how Medicaid Accountable Care Organizations can improve maternal healthcare quality and equity in the US by aligning performance mandates with innovative care coordination and social needs support among patients before, during, and after pregnancy.
West Nile cases rises to 5 people, Shelby County Health Department says
The Shelby County Health Department said that the number of patients testing positive for West Nile virus has increased slightly.
New Kansas initiative aims to keep mental health patients out of police cars
Kansas launches $2.46M search for statewide behavioral health transport network.
For St. Paul’s most vulnerable patients, the distance to healthcare is growing
St. Paul patients finally found accessible healthcare. Then the clinic closed.
How AI can improve patient access – beyond simply filling the next open slot
More precise navigation can improve provider matching, shorten time to intervention and help health systems measure whether digital access actually works.
PDS Health and United Concordia Launch Saliva Screening Pilot
United Concordia Dental and PDS Health®, leaders in oral health and dental-medical integration, respectively, launched a saliva screening pilot in Southern California earlier this week that aims to improve oral health and overall health by investigating the screening’s impact on periodontal (gum) disease management. According to the Centers for Disease Control and Prevention (CDC), more than 40% of U.S. adults over the age of 30 have some form of gum disease. Left untreated, this condition can lead to tooth loss and infections and is associated with systemic conditions such as heart disease, stroke and diabetes. “Gum disease is not just an oral health issue. It’s closely connected to a person’s well-being,” said Ed Shellard, DMD, president and CEO of United Concordia. “This partnership with PDS Health underscores our shared commitment to dental-medical integration and allows us to empower patients with on-the-spot data about the current status of their gum health.”…
Redesigning Urban Green Spaces for Nature-Based Healthcare
Doctors are increasingly mandating time in nature to treat patients' chronic diseases, mental health disorders, and sedentary lifestyles.
St. Ambrose health clinic seeks patients for no-cost rehabilitation services
St. Ambrose University’s Interprofessional Health Clinic is putting out the call for patients throughout the Quad Cities who need neurological rehabilitation services but face barriers to accessing traditional care. As of Tuesday, Sept. 1, the SAU student-led clinic began providing the free rehabilitation services on Tuesday evenings at the St. Ambrose University Center for Health […]
Patient preference science is changing how we define a better treatment
As we enjoy the last days of Summer and head into September, one of the clearest shifts we are seeing across life sciences is a surge in demand for patient preference science. Some of that momentum reflects the work of Kielo Health, Sanius Health’s preference science division, led by Dr Tommi Tervonen, Chief Scientist. The question behind the science is simple but increasingly important: when treatment choices involve trade-offs, what do patients actually value most today?
New LEAD model builds on REACH, offers role for home health agencies
As healthcare providers, including home health agencies, gear up for the start of the Long-term Enhanced ACO Design (LEAD) model on Jan. 1, they take comfort that the new model will continue the work of the soon-to-be-completed model, Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH), in serving high-needs patients with complex needs.
Orlando Health doctor and team bring life-changing medical care to Kenya
The team evaluated 250 patients for knee replacements over the course of several days.
Arbeloa on new signings, Tete and pressure of tough start
Fulham boss Alvaro Arbeloa has been speaking to the media before Saturday's Premier League game against Crystal Palace at Craven Cottage (kick-off 15:00 BST). All players are available except for Tom Cairney. Arbeloa confirmed deadline-day signings Hugo Larsson, Manuel Angel and David Affengruber will be in the squad but are not ready to start, adding: "Be patient with with these three players - they need to understand what we want from them."
Cyclosporiasis outbreak exposes a weakened US public health system
During the height of the summer outbreak of cyclosporiasis, Dea Lancaster set aside her usual duties as nurse coordinator at Michigan's Washtenaw County Health Department to call patients, asking about their symptoms and tracing the contaminated food they ate.
DaVita settles ransomware attack lawsuit for $15M
The 2025 data breach exposed records on 2.7 million patients. The cybercrime syndicate Interlock claimed credit for the attack, posting its stolen bounty on the dark web shortly after the incident.
Midwife from closed Iowa program joins Regional Health Services
She once cared for patients at a hospital that shut its doors to expecting mothers. Now, she’s continuing that work in a new place.
Ferguson moves to prepare WA for looming Medicaid changes
Gov. Bob Ferguson signed an executive order Thursday aimed at helping thousands of Washington patients who could soon lose Medicaid coverage.
Annual 5K supports Southcoast Health cancer patients in honor of doctor’s late wife
The 9th Annual Nicole Podkowa 5K is an opportunity for you to raise money to help individuals and their families battling cancer, while also remembering a woman who lost her own battle 10 years ago…